Cargando…
Identification of a Novel Risk Model: A Five-Gene Prognostic Signature for Pancreatic Cancer
OBJECTIVE: Biomarkers for pancreatic cancer (PCa) prognosis provide evidence for improving the survival outcome of this disease. This study aimed to identify a prognostic risk model based on gene expression profiling of microarray bioinformatics analysis. METHODS: Prognostic immune genes in the TCGA...
Autores principales: | Wang, Xiaoguang, Ni, Man, Han, Daxiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286972/ https://www.ncbi.nlm.nih.gov/pubmed/35845587 http://dx.doi.org/10.1155/2022/3660110 |
Ejemplares similares
-
Retracted: Identification of a Novel Risk Model: A Five-Gene Prognostic Signature for Pancreatic Cancer
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Identification of a Five-Gene Prognostic Signature Related to B Cells Infiltration in Pancreatic Adenocarcinoma
por: Tang, Shaomei, et al.
Publicado: (2021) -
Identification of a novel five ferroptosis-related gene signature as a promising prognostic model for breast cancer
por: Cheng, Tian- cheng, et al.
Publicado: (2023) -
Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers
por: Ghatak, Souvik, et al.
Publicado: (2022) -
Identification and validation of a five-gene prognostic signature for hepatocellular carcinoma
por: Yang, Huibin, et al.
Publicado: (2021)